Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2000
05/23/2000US6066723 Nucleotide sequence coding kinase modulator and cancer marker polypeptide; for the screening of biopsy tissue for detection of cancer; for the diagnosis and treatment of cancer
05/23/2000US6066719 Immunoglobulin heavy chain fragment associated with two light chains which each comprise a variable domain and form two functional antigen binding positions; for use in isolation of antibodies
05/23/2000US6066718 Culturing host encoding dna capable of expressing antibody against immunoglobulin e, isolating, and conjugating with an enzyme, a fluorescent or chemiluminescent marker, a cytotoxic or cytostatic substance, radioactive label or others
05/23/2000US6066717 RsbW-1 protein
05/23/2000US6066503 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
05/23/2000US6066501 Suppression of cell propagation using nucleic acid sequences which hybridizes prefrentially to sequences associated with the expression of human cell cycle propagation protein
05/23/2000US6066498 Compositions for the treatment and diagnosis of immune disorders
05/23/2000US6066475 Parathyroid cytosolic autoantigens recognized by autoantibodies from patients with acquired hypoparathyroidism
05/23/2000US6066472 Nucleotide sequences isolated from glioblastoma cdna library; for probes, primers, antisense agents, drug screening, anticarcinogenic agents
05/23/2000US6066451 Neural cell protein marker RR/B and DNA encoding the same
05/23/2000US6066323 Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
05/23/2000US6066322 Administering antibody to treat asthma; treating helper t-cell mediated conditions
05/23/2000US6066321 Diagnosing inflammation and autoimmune diseases
05/23/2000US6066320 Isolating antiserum with nerve cells presenting anti-prion protein
05/23/2000US6066319 Administering membrane attack complex (mac) transmembrane channel forming agent which is an antibody simultaneously therewith an effective amount of a therapeutic or diagnostic agent
05/23/2000CA2167630C Cdna of dock180 gene and dock180 protein
05/18/2000WO2000028319A1 Detection of preharvest sprouting in cereal grains
05/18/2000WO2000028052A2 Nucleic acid molecules from rice encoding an r1 protein and their use for the production of modified starch
05/18/2000WO2000028050A1 Method for expressing recombinant proteins using the effect of stress and stress response mechanisms in the presence of compatible solutes
05/18/2000WO2000028047A1 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use
05/18/2000WO2000028045A2 Human hydrolase proteins
05/18/2000WO2000028039A2 Identification of senv genotypes
05/18/2000WO2000028037A1 CATFIIIA CANDIDA ALBICANS tfIIIA GENE (CatfIIIA) AND THE CODED CATFIIIA PROTEIN
05/18/2000WO2000028034A2 Cytokine signal regulators
05/18/2000WO2000028030A1 Human secretory protein-61
05/18/2000WO2000028029A2 Cell surface glycoproteins
05/18/2000WO2000028027A2 Corticosteroid synthesis-associated genes
05/18/2000WO2000028002A1 Dna molecules encoding the melanocortin 5 receptor protein from rhesus monkey
05/18/2000WO2000028001A1 Modified exosomes and uses
05/18/2000WO2000027994A2 Chlamydia pneumoniae genome sequence
05/18/2000WO2000027884A1 Antibodies, mini-antibodies or antibody fragments binding to vitamin e and the use thereof
05/18/2000WO2000027879A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof
05/18/2000WO2000027874A2 Nucleic acids encoding transferrin receptor-like proteins and products related thereto
05/18/2000WO2000027870A1 Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
05/18/2000WO2000027868A2 Connective tissue growth factor (ctgf) and methods of use
05/18/2000WO2000027865A1 CHARACTERIZATION OF NOVEL GENE cbl-SL
05/18/2000WO2000027864A1 CHROMOSOME 17p-LINKED PROSTATE CANCER SUSCEPTIBILITY GENE
05/18/2000WO2000027863A1 Dna molecules encoding the melanocortin 4 receptor protein from rhesus monkey
05/18/2000WO2000027862A1 Dna molecules encoding the melanocortin 3 receptor protein from rhesus monkey
05/18/2000WO2000027433A1 Chimeric anti-cd20 antibody treatment of patients receiving bmt or pbsc transplants
05/18/2000WO2000027431A1 Method of treating arthritis with human parvovirus b19 antigens or antibodies against same
05/18/2000WO2000027428A1 Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-cd20 antibody
05/18/2000WO2000027410A2 Composition and method for increasing weight gain and feed efficiency
05/18/2000WO2000009730A3 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
05/18/2000WO2000009725A3 Method for recovering proteins from the interstitial fluid of plant tissues
05/18/2000WO2000009560A3 Generation of modified molecules with increased serum half-lives
05/18/2000WO2000008181A3 Chp polypeptide, a ligand of pak65
05/18/2000DE19850718C1 Zellpermeabilität-vermittelndes Polypeptid Cell permeability-mediating polypeptide
05/18/2000CA2351017A1 Catfiiia candida albicans tfiiia gene (catfiiia) and the coded catfiiia protein
05/18/2000CA2350775A1 Chlamydia pneumoniae genome sequence
05/18/2000CA2350621A1 Human secretory protein-61
05/18/2000CA2350388A1 Human hydrolase proteins
05/18/2000CA2350182A1 Connective tissue growth factor (ctgf) and methods of use
05/18/2000CA2350169A1 Dna molecules encoding the melanocortin 4 receptor protein from rhesus monkey
05/18/2000CA2350167A1 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use
05/18/2000CA2350087A1 Chromosome 17p-linked prostate cancer susceptibility gene
05/18/2000CA2350058A1 Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-cd20 antibody
05/18/2000CA2349951A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof
05/18/2000CA2349950A1 Dna molecules encoding the melanocortin 3 receptor protein from rhesus monkey
05/18/2000CA2349848A1 Dna molecules encoding the melanocortin 5 receptor protein from rhesus monkey
05/18/2000CA2349814A1 Cytokine signal regulators
05/18/2000CA2349761A1 Corticosteroid synthesis-associated genes
05/18/2000CA2349679A1 Modified exosomes and uses
05/18/2000CA2349449A1 Cell surface glycoproteins
05/18/2000CA2348727A1 Composition and method for increasing weight gain and feed efficiency
05/17/2000EP1001025A2 Outer membrane proteins from actinobacillus pleuropneumoniae
05/17/2000EP1001023A2 Frizzled-4, a putative Wnt-receptor
05/17/2000EP1001021A1 Monoclonal antibody to human CD21, and its uses
05/17/2000EP1001020A1 Antihuman pre-b cell receptor antibodies
05/17/2000EP1001019A1 Transgenic animals harboring APP Allele having Swedish mutation
05/17/2000EP1001017A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules
05/17/2000EP1000357A1 Antibodies and scfv immunotoxins specific to imported fire ants, and their application
05/17/2000EP1000177A1 Synthetic antigen for the detection of antibodies immunoreactive with hiv virus
05/17/2000EP1000172A1 Detection of targets with green fluorescent protein and fluorescent variants thereof
05/17/2000EP1000163A1 $i(PSEUDOMONAS) EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS
05/17/2000EP1000162A1 $i(PSEUDOMONAS) EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS FOR ELICITING A SECRETORY IGA-MEDIATED IMMUNE RESPONSE
05/17/2000EP1000159A1 Starch debranching enzymes
05/17/2000EP1000155A1 Immunogenic fragments of toxin a of clostridium difficile
05/17/2000EP1000145A1 Heart and skeleton muscle specific nucleic acid, the production and use thereof
05/17/2000EP1000143A1 Frazzled nucleotide sequences, expression products, compositions and uses
05/17/2000EP1000088A2 Process for the separation of specific immunoglobulins from standard plasma
05/17/2000EP1000087A2 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same
05/17/2000EP1000083A1 Oxidized styrenic polymers for dna binding
05/17/2000EP1000082A2 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
05/17/2000EP0999853A1 Stabilized antibody formulation
05/17/2000EP0934425A4 Renilla luciferase and green fluorescent protein fusion genes
05/17/2000EP0738394B1 Ubiquitin conjugating enzymes
05/17/2000EP0703922B1 Method for producing immunoglobulin g concentrate
05/17/2000EP0601106B1 Morphogen-induced modulation of inflammatory response
05/17/2000EP0574461B1 High affinity humanized monoclonal antibodies
05/17/2000CN1253593A Expression of herbicide-binding polypeptides in plants to produce herbicide tolerance
05/17/2000CN1253592A DNA sequences coding for subunit child of plant magnesium chelatases and method for determining their action
05/17/2000CN1253589A Human complement C3-degrading proteinase from streptococcus pneumoniae
05/17/2000CN1253567A Cell surface molecule mediating cell adhesion and signal transmission
05/17/2000CN1253180A Specific protein of human neuroendocrine, coding sequence and its preparating process and application
05/17/2000CN1253176A Composition and method for protecting animals from diseases related with slow action virus
05/16/2000US6063913 Stable heterologous propagation CFTR protein variant cDNA
05/16/2000US6063909 Preparation of factor IX
05/16/2000US6063907 In vitro methods for determining in vivo thrombotic events
05/16/2000US6063906 Antibodies to integrin alpha subunit